Insulin therapy in type 2 diabetes
DOI:
https://doi.org/10.32385/rpmgf.v21i6.10191Abstract
Diabetes mellitus type 2 (D2) is characterized by progressive failure of pancreatic beta cells, associated with a variable degree of peripheral insulin resistance. Changes in lifestyle can be effective in controlling blood glucose levels in many patients with early D2. However, as the disease progresses and evolves, their treatment is by the use, in addition to diet and exercise, oral antidiadiabéticos (AO) and after the addition of insulin to oral therapy. The indications for the use of exogenous insulin in patients with D2 include acute illness, surgery, pregnancy, glucotoxicidade, contraindication to the use, or inability to achieve the objectives of treatment with AO1. Add basal insulin treatment becomes helpful if there is any residual beta cell function. Already the replacement therapy with basal-bolus insulin is required if there is beta cell exhaustion. An emergency treatment with insulin replacement for a few weeks can reverse glucotoxicidade.Downloads
Downloads
Published
Issue
Section
License
The authors will assign to the RPMGF the sole right to publish and distribute the content of the manuscript specified in this declaration via physical, electronic, broadcasting or any other medium that may come into existence. They also grant the RPMGF the right to use and exploit this manuscript, in particular by assigning, selling or licensing its content. This permission is permanent and takes effect from the moment the manuscript is submitted, has the maximum duration allowed by applicable Portuguese or international law and is of worldwide scope. The authors further declare that this assignment is made free of charge. If the RPMGF informs the authors that it is not going to publish their manuscript, the exclusive assignment of rights ceases forthwith.
The authors authorise the RPMGF (or any entity it may appoint) to act on their behalf when it believes that copyright may have been infringed.
